Combined Therapeutics to Present at 11th International mRNA Health Conference

BOSTON, Oct. 25, 2023 /PRNewswire/ — Combined Therapeutics Inc. (CTx), a privately held biotechnology company developing the next generation of mRNA therapeutics with a novel modified-mRNA platform to treat and prevent infectious diseases and cancer, today announced the participation of Romain Micol, M.D., MPH, Ph.D., President and CEO of Combined Therapeutics, as a speaker at the 11^th International mRNA Health Conference, taking place Oct. 31-Nov. 2, 2023, in Berlin, Germany.